|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 65.49 USD | +0.37% |
|
+4.73% | -15.79% |
| 05/12 | Health Rounds: Shingles vaccine reduces risk of death from dementia, study finds | RE |
| 04/12 | Dexcom Launches New Education Offering, Dexcom Academy | CI |
| Capitalization | 2.54TCr 2.19TCr 2.05TCr 1.91TCr 3.53TCr 2,29000Cr 3.84TCr 24TCr 9.26TCr 1,08200Cr 9.55TCr 9.35TCr 3,95500Cr | P/E ratio 2025 * |
31.7x | P/E ratio 2026 * | 27.1x |
|---|---|---|---|---|---|
| Enterprise value | 2.56TCr 2.2TCr 2.06TCr 1.92TCr 3.55TCr 2,30400Cr 3.86TCr 24TCr 9.31TCr 1,08800Cr 9.61TCr 9.4TCr 3,97900Cr | EV / Sales 2025 * |
5.51x | EV / Sales 2026 * | 4.75x |
| Free-Float |
95.22% | Yield 2025 * |
-
| Yield 2026 * | - |
Last Transcript: DexCom, Inc.
| 1 day | +0.37% | ||
| 1 week | +4.73% | ||
| Current month | +3.18% | ||
| 1 month | +7.04% | ||
| 3 months | -18.91% | ||
| 6 months | -23.50% | ||
| Current year | -15.79% |
| 1 week | 62.32 |  | 66.75 |
| 1 month | 54.11 | | 66.75 |
| Current year | 54.11 | | 93.25 |
| 1 year | 54.11 | | 93.25 |
| 3 years | 54.11 | | 142 |
| 5 years | 54.11 | | 164.86 |
| 10 years | 10.66 | | 164.86 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jacob Leach
CEO | Chief Executive Officer | 46 | 14/09/2025 |
Jereme Sylvain
DFI | Director of Finance/CFO | 45 | 19/03/2021 |
| Chief Tech/Sci/R&D Officer | 48 | 01/10/2022 |
| Director | Title | Age | Since |
|---|---|---|---|
Nick Augustinos
BRD | Director/Board Member | 66 | 20/11/2009 |
Steven Altman
BRD | Director/Board Member | 63 | 07/11/2013 |
Mark Foletta
CHM | Chairman | 65 | 14/09/2025 |
| Name | Weight | AuM | Varia. Jan 1. | Investor |
|---|---|---|---|---|
 | 1.46% | 26 M€ | +11.73% | - |
| Change | 5d. change | 1-year change | 3-years change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.37% | +4.73% | -19.16% | -44.55% | 2.54TCr | |
| -0.26% | -2.69% | +7.86% | +15.72% | 22TCr | |
| -0.62% | -3.49% | +18.80% | +27.30% | 13TCr | |
| +0.60% | -7.83% | +36.77% | +95.22% | 6.55TCr | |
| +0.10% | +0.03% | -12.41% | -23.15% | 5.53TCr | |
| +0.25% | +2.09% | +20.19% | +70.41% | 5.21TCr | |
| +0.87% | -1.34% | +21.19% | +37.19% | 2.56TCr | |
| -0.33% | +5.07% | +17.94% | -37.25% | 2.43TCr | |
| -2.23% | -2.27% | -23.56% | +17.98% | 2.31TCr | |
| -3.62% | -6.83% | +13.11% | -1.16% | 2.22TCr | |
| Average | -0.49% | -0.77% | +8.07% | +15.77% | 6.42TCr | |
| Weighted average by Cap. | -0.29% | -1.95% | +11.18% | +23.24% |
| 2025 * | 2026 * | |
|---|---|---|
| Net sales | 464.49Cr 399.28Cr 374.04Cr 348.63Cr 643.93Cr 42TCr 700.41Cr 4.38TCr 1.69TCr 20TCr 1.74TCr 1.71TCr 72TCr | 523.32Cr 449.84Cr 421.41Cr 392.78Cr 725.48Cr 47TCr 789.11Cr 4.93TCr 1.9TCr 22TCr 1.96TCr 1.92TCr 81TCr |
| Net income | 83Cr 71Cr 67Cr 62Cr 115.23Cr 7.48TCr 125.34Cr 782.92Cr 302.3Cr 3.53TCr 311.98Cr 305.32Cr 13TCr | 99Cr 85Cr 80Cr 74Cr 137.15Cr 8.9TCr 149.18Cr 931.84Cr 359.8Cr 4.21TCr 371.32Cr 363.39Cr 15TCr |
| Net Debt | 15Cr 13Cr 12Cr 11Cr 21Cr 1.37TCr 23Cr 143.64Cr 55Cr 648.22Cr 57Cr 56Cr 2.37TCr | -59Cr -50Cr -47Cr -44Cr -81Cr -5.28TCr -88Cr -552.79Cr -213.44Cr -2.49TCr -220.27Cr -215.57Cr -9.12TCr |
| Date | Price | Change | Volume |
|---|---|---|---|
| 05/25/05 | 65.49 $ | +0.37% | 38,11,429 |
| 04/25/04 | 65.25 $ | +0.62% | 34,84,310 |
| 03/25/03 | 64.85 $ | +0.62% | 37,10,786 |
| 02/25/02 | 64.45 $ | +1.46% | 47,99,533 |
| 01/25/01 | 63.52 $ | +0.08% | 52,09,243 |
Delayed Quote Nasdaq, December 06, 2025 at 02:30 am IST
More quotes
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Global Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Global Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite), and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of the rankings based on the following ratings: Capital Efficiency (Composite), Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully review the associated descriptions.
Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- DXCM Stock
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition